Robert Willett, a director at $CGNX, sold 173,296 shares of the company on 02-12-2026 for an estimated $10,117,904. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $CGNX stock.
$CGNX Insider Trading Activity
$CGNX insiders have traded $CGNX stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CGNX stock by insiders over the last 6 months:
- ROBERT WILLETT has made 0 purchases and 3 sales selling 183,756 shares for an estimated $10,669,088.
- LAURA ANN MACDONALD (VP and PAO) has made 0 purchases and 3 sales selling 17,547 shares for an estimated $970,523.
- SHEILA MARIE DIPALMA (EVP, Employee Services) has made 0 purchases and 2 sales selling 4,002 shares for an estimated $180,150.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CGNX Hedge Fund Activity
We have seen 259 institutional investors add shares of $CGNX stock to their portfolio, and 279 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO added 10,471,400 shares (+173138.2%) to their portfolio in Q4 2025, for an estimated $376,760,971
- POINT72 ASSET MANAGEMENT, L.P. added 2,123,919 shares (+343.6%) to their portfolio in Q3 2025, for an estimated $96,213,530
- ALYESKA INVESTMENT GROUP, L.P. added 1,900,718 shares (+inf%) to their portfolio in Q4 2025, for an estimated $68,387,833
- MACKENZIE FINANCIAL CORP removed 1,674,808 shares (-36.3%) from their portfolio in Q3 2025, for an estimated $75,868,802
- PICTET ASSET MANAGEMENT HOLDING SA added 1,529,010 shares (+27.9%) to their portfolio in Q4 2025, for an estimated $55,013,779
- SWEDBANK AB removed 1,400,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $50,371,999
- D. E. SHAW & CO., INC. removed 1,301,165 shares (-94.7%) from their portfolio in Q3 2025, for an estimated $58,942,774
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CGNX Revenue
$CGNX had revenues of $252.3M in Q4 2025. This is an increase of 9.86% from the same period in the prior year.
You can track CGNX financials on Quiver Quantitative's CGNX stock page.
$CGNX Analyst Ratings
Wall Street analysts have issued reports on $CGNX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 12/16/2025
- JP Morgan issued a "Underweight" rating on 12/03/2025
- Needham issued a "Buy" rating on 10/31/2025
- Barclays issued a "Overweight" rating on 10/31/2025
To track analyst ratings and price targets for $CGNX, check out Quiver Quantitative's $CGNX forecast page.
$CGNX Price Targets
Multiple analysts have issued price targets for $CGNX recently. We have seen 7 analysts offer price targets for $CGNX in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Ken Newman from Keybanc set a target price of $70.0 on 02/13/2026
- Guy Hardwick from Barclays set a target price of $61.0 on 02/13/2026
- James Ricchiuti from Needham set a target price of $67.0 on 02/12/2026
- Jamie Cook from Truist Securities set a target price of $42.0 on 12/18/2025
- Joe Ritchie from Goldman Sachs set a target price of $50.0 on 12/16/2025
- Tomohiko Sano from JP Morgan set a target price of $35.0 on 12/03/2025
- Matthew Summerville from DA Davidson set a target price of $38.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
